Template:Table of severe drug reactions: Difference between revisions

Line 3: Line 3:
| align="center" style="background:#f0f0f0;"|'''Charateristic'''
| align="center" style="background:#f0f0f0;"|'''Charateristic'''
| align="center" style="background:#f0f0f0;"|'''[[DRESS]]'''
| align="center" style="background:#f0f0f0;"|'''[[DRESS]]'''
| align="center" style="background:#f0f0f0;"|'''SJS/TEN'''
| align="center" style="background:#f0f0f0;"|'''[[SJS/TEN]]'''
| align="center" style="background:#f0f0f0;"|'''AGEP'''
| align="center" style="background:#f0f0f0;"|'''AGEP'''
| align="center" style="background:#f0f0f0;"|'''Erythroderma'''
| align="center" style="background:#f0f0f0;"|'''Erythroderma'''

Revision as of 19:08, 17 December 2019

Table of Severe Drug Reactions

Charateristic DRESS SJS/TEN AGEP Erythroderma
Onset of eruption 2-6 weeks 1-3 weeks 48 hours 1-3 weeks
Duration of eruption (weeks) Several 1-3 <1 Several
Fever +++ +++ +++ +++
Mucocutaneous features Facial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesions Bullae, atypical target lesions, mucocutaneous erosions Facial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvement Erythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
Histological pattern of skin Perivascular lymphocytcic infiltrate Epidermal necrosis Subcorneal pustules Nonspecific, unless reflecting Sezary syndrome or other lymphoma
Lymph node enlargement +++ - + +
Lymph node histology Lymphoid hyperplasia - - No, unless reflecting Sezary syndrome or other malignancy
Hepatitis +++ ++ ++ -
Other organ involvement Interstitial nephritis, pneumonitis, myocarditis, and thydoiditis Tubular nephritis and tracheobronical necrosis Possible Possible
Neutrophils Elevated Decreased Very elevated Elevated
Eosinophils Very elevated No change Elevated Elevated
Atypical lymphocytes + - - +
Mortality (%) 10 5-35 5 5-15
AGEP Acute generalized exanthematous pustulosis
DRESS drug reaction with eosinophilia and systemic symptoms
SJS Stevens-Johnson syndrome
TEN toxic epidermal necrolysis